Related Experiment Video
Updated: Feb 27, 2026

Formulations for Freeze-drying of Bacteria and Their Influence on Cell Survival
Published on: August 3, 2013
Sucrose Octaacetate Chemical Kinetics and Shelf Lives at Various Formulation pHs
Shalini Gaddam1,2, William C Stagner3
1Department of Pharmaceutical Sciences, Campbell University College of Pharmacy & Health Sciences, Buies Creek, North Carolina, USA.
Sucrose octaacetate (SOA) stability was studied to determine optimal formulation conditions. SOA is best formulated at pH 5.40 and refrigerated at 4°C for long-term use, offering stability for pediatric drug development.
Area of Science:
- Pharmaceutical Sciences
- Chemical Kinetics
- Drug Formulation
Background:
- Developing pediatric-friendly dosage forms is crucial globally.
- Sucrose octaacetate (SOA) is a recommended surrogate for bitter active pharmaceutical ingredients.
- Rigorous chemical kinetic and stability studies for SOA are lacking.
Purpose of the Study:
- To conduct chemical kinetic and stability studies on Sucrose octaacetate (SOA).
- To determine optimal formulation conditions for SOA shelf life.
- To provide data for developing stable SOA formulations.
Main Methods:
- Utilized a recently reported SOA stability-indicating method.
- Performed chemical kinetic studies including reaction order and activation energies.
- Generated pH-rate profiles at 4°C and 25°C.
Main Results:
- Estimated SOA shelf lives varied significantly with pH and temperature.
- At 25°C, shelf lives ranged from 25.3 days (pH 4.00) to 114 days (pH 5.20).
- At 4°C, shelf lives extended to 5.26 years (pH 5.20), with an optimum at pH 5.40.
Conclusions:
- SOA can be formulated at pH 4-6 for short-term use (e.g., taste studies) at 25°C.
- For long-term applications (e.g., clinical trials), formulate SOA at pH 5.40 and refrigerate at 4°C.
- The study provides essential data for stable SOA formulation and shelf-life estimation.
More Related Videos
Related Concept Videos
Drug Product Stability
Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Factors Affecting Solubility
Bioavailability Enhancement: Drug Solubility Enhancement
Factors Influencing Drug Absorption: Pharmaceutical Parameters

